China Universal Asset Management Company’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Buy |
|
|||||
|
2025
Q1 | $88.1K | Sell |
|
|||||
|
2024
Q4 | $98.1K | Buy |
|
|||||
|
2024
Q3 | $75.8K | Buy |
|
|||||
|
2024
Q2 | $48.4K | Sell |
|
|||||
|
2024
Q1 | $86K | Buy |
|
|||||
|
2023
Q4 | $64.7K | Buy |
|
|||||
|
2023
Q3 | $11.7K | Buy |
|
|||||
|
2023
Q2 | $7.83K | Sell |
|
|||||
|
2023
Q1 | $9.91K | Buy |
|
|||||
|
2022
Q4 | $7.67K | Sell |
|
|||||
|
2022
Q3 | $7K | Buy |
|